Martin Shkreli, the 32 year old pharmaceutical mogul who hiked the price of an HIV-related drug by 5,000 percent, was arrested by the FBI, at his Manhattan condo, and hid indictment accused him of orchestrating a “trifecta of lies, deceit and greed.”
A review of the unsealed indictment overviews the former hedge fund manager-turned-pharmaceutical company CEO and a multi-layered securities fraud scheme involving the publicly-traded pharma company Retrophin LLC, which fired Shkreli as its CEO in 2014. Shkreli Indictment
Shkreli, was taken into custody at his Manhattan residence. He is the head of Turing Pharmaceuticals and KaloBios Pharmaceuticals and was previously the manager of hedge fund MSMB Capital Management and chief executive of biopharmaceutical company Retrophin Inc.